1. Market Research
  2. > Healthcare Market Trends
  3. > IMS Pharmaceutical Pricing & Reimbursement Concise Guide: Portugal

The Pharmaceutical Pricing & Reimbursement Concise Guides are established as the definitive reference and training text for P&R professionals around the world, drawing on the long-standing expertise of the IMS pricing and reimbursement specialists to provide industry players and decision makers with a thorough understanding of the rules and regulations governing P&R in international markets. This report covers key developments in P&R, market access, cost containment, trade margins and healthcare issues.

Table Of Contents

IMS Pharmaceutical Pricing and Reimbursement Concise Guide: Portugal
PORTUGAL 1
HEALTHCARE SYSTEM..1
Facts and Figures ..1
Market Indicators2
Provision and Funding ...4
Healthcare Cover.4
Healthcare Funding .5
Policy, Regulation and Provision.5
PRICING...6
Prescription Drugs..6
Legislative Framework.6
Application ...6
Non-reimbursed Prescription Drugs 8
Generic Drugs 8
Pricing Rules8
Reference Price System..9
Annual Price Reviews..9
Hospital Drugs9
Pricing Rules9
Purchasing.10
Hospital Debts ...10
OTC Drugs ...10
REIMBURSEMENT 10
Admission to Reimbursement ..10
Procedure ..11
Reimbursement Contracts.12
Timeline and Results .13
INFARMED Reviews .14
Reimbursement Categories .14
General Scheme14
Special Schemes...14
Exceptional Use Authorisation...15
Reimbursement Prices.16
Reference Price System16
Hospital Reimbursement..16
Assessment ...16
Formularies17
Funding..18
High-cost Out-patient Drugs ..18
Changes in Reimbursement Status .18
INFARMED Reviews .18
Post-marketing Assessments 19
Reimbursement Categories...19
Changes in Reimbursement Prices .20
Annual Price Reviews20
Price Notification System...21
Manufacturers' Price Revisions .21
Exceptional Price Revisions ..22
Reference Price Revisions 22
Post-marketing Assessments 22
PHARMACOECONOMICS.22
Pharmacoeconomic Requirements..22
Decree-law 97/2015 ..22
Initial Economic Assessment.23
Post-marketing Assessment..24
PRICE BUILD UP ...24
Wholesalers .24
Margins ..24
Discounts ...25
Background25
Retail Pharmacies 25
Margins ..25
Discounts ...26
Cheap Generic Dispensing Fee 26
Background26
OTCs .27
E-pharmacy ...27
Other Issues ..28
Dispensing Doctors ..28
Sales Tax .28
COST CONTAINMENT ..28
Industry Paybacks28
2016-2018 Agreement...28
Direct Tax on Sales ...29
Promotional Costs29
Patient Co-payments30
Pharmaceuticals 30
Healthcare .30
Prescribing Controls.31
Physician Monitoring .31
INN Prescribing .32
Generic Substitution ..32
E-prescribing..32
Prescribing Software .32
Hospital Prescribing...32
Post-marketing Assessments 33
Generics...33
Generic Substitution ..33
INN Prescribing .33
Pharmacy Incentives .33
Rx-to-OTC Switches 34
Switch Process ..34
OTC Sales .35
Market35
Parallel Trade...35
Parallel Exports .35
Parallel Imports..36
FUTURE DEVELOPMENTS ..36
Outlook.36
2017 Price Reviews...36
National Strategy for Drugs and Health Products .37
National Health Plan..38
National Patient Safety Plan 2015-20 ...38
NAMES and ADDRESSES 39

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Ahmad

+1 718 618 4302

Purchase Reports From Reputable Market Research Publishers
PharmaPoint: Psoriatic Arthritis - Global Drug Forecast and Market Analysis to 2025

PharmaPoint: Psoriatic Arthritis - Global Drug Forecast and Market Analysis to 2025

  • $ 10995
  • Industry report
  • December 2016
  • by GlobalData

PharmaPoint: Psoriatic Arthritis - Global Drug Forecast and Market Analysis to 2025 Summary Psoriatic arthritis (PsA) is a chronic immune-mediated arthritis typically affecting the large joints, especially ...

OpportunityAnalyzer: Diabetic Foot Ulcers - Opportunity Analysis and Forecast to 2025

OpportunityAnalyzer: Diabetic Foot Ulcers - Opportunity Analysis and Forecast to 2025

  • $ 10995
  • Industry report
  • December 2016
  • by GlobalData

OpportunityAnalyzer: Diabetic Foot Ulcers - Opportunity Analysis and Forecast to 2025 Summary Diabetic Foot Ulcer (DFU) and Diabetic Foot Infection (DFI) market is set to triple in value from $292.1 Million ...

PharmaPoint: Hepatitis C Virus (HCV) Therapeutics - Global Drug Forecast and Market Analysis to 2025

PharmaPoint: Hepatitis C Virus (HCV) Therapeutics - Global Drug Forecast and Market Analysis to 2025

  • $ 10995
  • Industry report
  • December 2016
  • by GlobalData

PharmaPoint: Hepatitis C Virus (HCV) Therapeutics - Global Drug Forecast and Market Analysis to 2025 Summary Hepatitis C virus (HCV) is a small, enveloped RNA virus that causes acute and chronic infections ...


Download Unlimited Documents from Trusted Public Sources

Maternal Health Markets in the US - Forecast

  • March 2017
    7 pages
  • Maternal Health  

    Health Care Pro...  

  • United States  

View report >

Hepatitis Statistics and Therapy Market in the UK

  • March 2017
    10 pages
  • Hepatitis  

    Therapy  

    Antiviral  

  • United Kingdom  

View report >

Urology Industry in the US

  • March 2017
    142 pages
  • Urology  

    Hormone  

    Therapy  

  • United States  

View report >

Diabetes Statistics

5 days ago

Related Market Segments :

Health Care Provider
Hospital

ref:plp2016

Reportlinker.com © Copyright 2017. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.